SINTX Opens 3D Printing Facility in Salt Lake City
The site adds EXT-220 MED medical-grade printers for silicon nitride-PEEK orthopedic implants.
Updated on Nov. 16, 2026 in Materials Science

SINTX Technologies has completed a 3D printing facility in Salt Lake City, Utah, and received EXT-220 MED medical-grade 3D printers there. The company is developing patient-specific orthopedic implants using its SiN/PEEK composite through its SiNERGY additive manufacturing platform.
Why it matters
Silicon nitride is added to PEEK to limit bacterial adhesion and support bone growth, according to laboratory studies cited by the company. The composite also does not block X-ray imaging, a practical consideration for implants used in spinal and craniomaxillofacial procedures.
The figure comes from an in vitro study comparing bacterial adhesion on 3D printed spinal cages made of SiN/PEEK and standard PEEK, which showed a 93.9% reduction. Whether this laboratory result translates to reduced infection in patients has not been established.
The players
SINTX Technologies
SINTX Technologies is a Utah-based materials company developing silicon nitride ceramic technologies for medical and orthopedic applications.
Evonik
Evonik is a German specialty chemicals company that will supply SINTX with its proprietary SiN/PEEK compounded filament.
3DCERAM Sinto
3DCERAM Sinto is a French ceramics company that began developing a silicon nitride-based resin for ceramic 3D printing with SINTX in 2023.
The details
SINTX is also hiring and exploring AI tools to segment medical images and design implants for each patient, and it began work with 3DCERAM Sinto on a silicon nitride-based resin for ceramic 3D printing in 2023. The company is working toward FDA 510(k) clearance covering a set range of patient-specific extremity implants.
Timeline
2023: SINTX began working with 3DCERAM Sinto on a silicon nitride-based resin for ceramic 3D printing.
Year-end 2026: SINTX anticipates receiving its proprietary SiN/PEEK compounded filament from Evonik.
Q1 2027: A limited number of eligible custom devices could be supplied.
Later in 2027: Craniomaxillofacial and spinal applications would follow, depending on regulatory review.
Big Picture
PEEK has been widely used in spinal implants, but its inability to block X-rays and its susceptibility to bacterial colonization have driven efforts to modify it. SINTX's SiN/PEEK composite follows that line of development by adding a bioactive ceramic to the polymer.
If approved, patients receiving custom extremity implants could see devices designed to resist bacterial colonization and remain visible on X-ray imaging. Timing depends on FDA clearance and supplier deliveries that have not yet occurred.
The takeaway
Materials that combine ceramic surfaces with established polymers are advancing toward clinical use, but laboratory results must be confirmed in patient outcomes before they change treatment standards.
What happens next
SINTX expects to receive its SiN/PEEK filament from Evonik by year-end 2026, with limited custom device supply possibly beginning in Q1 2027.
Further reading
For related coverage, explore Materials Science reporting on engineered composites and their applications.
Source note: This article includes information reported by 3D ADEPT MEDIA.










